have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

Congrats to @oNKo_innate: Emerging Company of the Year at the 2021 #AusBiotech & @JNJInnovation Industry Excellence Awards. Dedicated to how the immune system may be better harnessed to treat cancer, it is a true exemplar of a uni-industry partnership success. @connell_kathy

Load More...
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
o o
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are